Aticaprant

N/A

Report date: 2025/01/10 16:06:53
NME

Base Information

Drug NameAticaprant
Drug Alias NameCERC-501AVTX-501LY-2456302JNJ-3964JNJ-67953964 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor antagonists
TargetsKappa opioid receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety Disorders +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[31] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson (China) Investment LtdJanssen Research & Development LlcPatheon Inc
Inactive CompaniesJanssen Pharmaceuticals IncYale UniversityEli Lilly And Company +[4] 
Active IndicationsDepressive Disorder, MajorAnhedonia
Inactive IndicationsDepressive DisorderAnxiety DisordersSmoking Cessation +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG